Ivermectin Shortage Update: What Patients Need to Know in 2026

Ivermectin has had a rollercoaster few years when it comes to pharmacy availability. If you're trying to fill a prescription in 2026 and running into trouble, here's a clear-eyed look at the current situation — what's actually happening with supply, what history tells us, and what you can do right now.

Current Ivermectin Shortage Status (2026)

As of early 2026, ivermectin tablets are not listed on the FDA's official Drug Shortage Database as a nationwide market-wide shortage. This is meaningful — it means large-scale manufacturing disruptions are not currently documented.

However, "not on the shortage list" does not mean "available everywhere." Many patients continue to report difficulty finding ivermectin at their local pharmacy, particularly in rural areas, smaller markets, and regions where recent demand has spiked due to parasitic disease activity. The FDA shortage database only captures nationwide supply crises — localized distribution gaps fall through the cracks.

What Caused the Ivermectin Shortage? A Brief History

To understand 2026's availability challenges, it helps to know what happened in 2021 and 2022. During the COVID-19 pandemic, widespread misinformation falsely promoted ivermectin as an effective treatment or preventive measure for COVID-19. The FDA repeatedly clarified that ivermectin is not approved or effective for COVID-19, and multiple large clinical trials confirmed it offered no benefit for the disease.

Despite this, demand for ivermectin exploded. Pharmacies that normally stocked modest quantities for parasitic disease treatment were suddenly overwhelmed with prescriptions. Poison control centers reported sharp increases in calls related to ivermectin overdose — largely from people taking veterinary formulations designed for horses and cattle.

Generic drug manufacturers — who produce ivermectin on shared production lines with other medications — struggled to scale up rapidly enough. The result was widespread stock-outs at pharmacies across the country. While the acute crisis resolved as COVID-19 treatment protocols evolved and demand normalized, supply chains didn't fully snap back to their previous state.

What's Driving Availability Problems in 2026?

Several factors continue to affect ivermectin availability for patients with legitimate medical needs:

• Residual distribution caution: Distributors burned by the 2021-2022 volatility remain conservative about inventory levels. This keeps systemic supply adequate but leaves individual pharmacies thin on stock.
• OTC expansion effects: Four states — Tennessee, Arkansas, Idaho, and Louisiana — have passed laws allowing over-the-counter sale of ivermectin as of 2025. This is changing how pharmacies in those states stock and display the medication, creating some transitional confusion about availability.
• Scabies outbreak clustering: Scabies outbreaks in facilities (nursing homes, correctional facilities, schools) can rapidly deplete pharmacy stock in a local area. Entire households may be treated simultaneously, requiring large quantities quickly.
• Tropical medicine demand fluctuation: Travel to tropical regions continues to increase, and returning travelers with parasitic infections (strongyloidiasis, onchocerciasis) can drive regional demand spikes.

What Should Patients Do Right Now?

If you're struggling to find ivermectin in 2026, here are immediate steps to take:

1. Call multiple pharmacies, including independents, warehouse clubs, and grocery store pharmacies — not just major chains.
2. Use medfinder — medfinder calls pharmacies near you and texts you the results so you don't have to spend hours on hold.
3. Ask your doctor if an alternative medication is appropriate for your condition while you locate ivermectin.
4. Consider mail-order pharmacy for non-urgent prescriptions — supply is often more reliable than retail pharmacy.

What Medications Are Safe Alternatives During a Shortage?

The alternatives depend on what ivermectin was prescribed for. For scabies, permethrin 5% cream is the most commonly recommended topical substitute. For strongyloidiasis, albendazole is the primary alternative. For head lice (Sklice), permethrin 1% lotion (Nix) is widely available OTC. See our full guide on ivermectin alternatives for more detail.

The Bottom Line for 2026

Ivermectin is not in a formally declared nationwide shortage as of 2026. The medication is available — but not uniformly so. Patients who live in areas with lower pharmacy density, or who need the medication urgently due to a scabies outbreak, may encounter real barriers to access. Knowing how to search effectively — and having a backup plan — is essential.